Loading...
Last submissions
-
Marion Alcantara, Marion Chevrier, Fabrice Jardin, Anna Schmitt, Caroline Houillier, et al.. Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients. Journal of Hematology and Oncology, 2024, 17 (1), pp.86. ⟨10.1186/s13045-024-01606-w⟩. ⟨hal-04719788⟩
-
Marion Alcantara, Marion Chevrier, Fabrice Jardin, Anna Schmitt, Caroline Houillier, et al.. Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients. Journal of Hematology and Oncology, 2024, 17 (1), pp.86. ⟨10.1186/s13045-024-01606-w⟩. ⟨hal-04719756⟩
-
Ugo Szachnowski, Oliver Sallou, Matéo Boudet, Anthony Bretaudeau, Maxime Wéry, et al.. The 5-Fluorouracil RNA Expression Viewer (5-FUR) Facilitates Interpreting the Effects of Drug Treatment and RRP6 Deletion on the Transcriptional Landscape in Yeast. Yeast, 2024, Online ahead of print. ⟨10.1002/yea.3982⟩. ⟨hal-04718291⟩
-
Lia M Pinto, Alexandros Pailas, Max Bondarchenko, Abhishek Bharadwaj Sharma, Katrin Neumann, et al.. DAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaks. Nucleic Acids Research, 2024, 52, pp.1136 - 1155. ⟨10.1093/nar/gkad1141⟩. ⟨hal-04716990⟩
-
Marcela Carausu, Matthieu Carton, Luc Cabel, Anne Patsouris, Christelle Levy, et al.. Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database. Therapeutic Advances in Medical Oncology, 2022, 14, pp.175883592210770. ⟨10.1177/17588359221077082⟩. ⟨hal-03867853⟩
-
Hugo Garcia, Alice Serafin, Flora Silbermann, Esther Porée, Amandine Viau, et al.. Agonists of prostaglandin E 2 receptors as potential first in class treatment for nephronophthisis and related ciliopathies. Proceedings of the National Academy of Sciences of the United States of America, 2022, 119 (18), pp.e2115960119. ⟨10.1073/pnas.2115960119⟩. ⟨hal-03930843⟩
-
Emilia Benassai, Ana C Hortelao, Elif Aygun, Asli Alpman, Claire Wilhelm, et al.. High-throughput large scale microfluidic assembly of iron oxide nanoflowers@PS- b -PAA polymeric micelles as multimodal nanoplatforms for photothermia and magnetic imaging. Nanoscale Advances, 2023, 6 (1), pp.126-135. ⟨10.1039/D3NA00700F⟩. ⟨hal-04711159⟩
-
Vincent Hautefeuille, Nicolas Williet, Anthony Turpin, Bertrand Napoleon, Aurélien Dupré, et al.. Ampullary tumors: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, ACHBT, AFC, SFRO, RENAPE, SNFCP, AFEF, SFP, SFR). Digestive and Liver Disease, 2024, 56 (9), pp.1452-1460. ⟨10.1016/j.dld.2024.04.027⟩. ⟨hal-04603000⟩
-
Martin Reck, Ernest Nadal, Nicolas Girard, Andrea R. Filippi, Linda W. Martin, et al.. MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB-IIIB NSCLC. Clinical Lung Cancer, 2024, 25 (6), pp.587-593.e3. ⟨10.1016/j.cllc.2024.06.007⟩. ⟨hal-04684299⟩